| Application no. and date | 19758683.7 (espacenet) (Federated) (European Patent Register), 20190821 | | Patent/reg. no. and date | DK/EP 3840837, 20240320 | | Publication date | 20210630 | | Priority no. and date | US 201862721113 P, 20180822 | | EP pub. no. and date |
EP 3840837 20210630 | | Effective date | | | Applicant/owner | Astrazeneca AB, 151 85 Södertälje, SE | | Applicant ref. no. | 1669811 | | Inventor | WU, Dedong, AstraZeneca R&D Boston 35 Gatehouse Drive
Waltham, MA 02451, US | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | | Opponent | | | IPC Class | A61K 31/69 (2006.01) , A61K 33/22 (2006.01) , A61P 29/00 (2006.01) , A61P 35/00 (2006.01) , C07F 5/02 (2006.01) | | Title | ARGINASEHÆMMERE OG FREMGANGSMÅDER TIL ANVENDELSE DERAF | | Int. application no. | EP2019072341 | | Int. publication no. | WO2020038983 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
